chr8-100920742-G-C
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM1PM2PP2PP3_ModeratePP5
The NM_145690.3(YWHAZ):c.689C>G(p.Ser230Trp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: not found (cov: 30)
Consequence
YWHAZ
NM_145690.3 missense
NM_145690.3 missense
Scores
11
6
2
Clinical Significance
Conservation
PhyloP100: 7.68
Genes affected
YWHAZ (HGNC:12855): (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta) This gene product belongs to the 14-3-3 family of proteins which mediate signal transduction by binding to phosphoserine-containing proteins. This highly conserved protein family is found in both plants and mammals, and this protein is 99% identical to the mouse, rat and sheep orthologs. The encoded protein interacts with IRS1 protein, suggesting a role in regulating insulin sensitivity. Several transcript variants that differ in the 5' UTR but that encode the same protein have been identified for this gene. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
PM1
In a chain 14-3-3 protein zeta/delta (size 244) in uniprot entity 1433Z_HUMAN there are 6 pathogenic changes around while only 0 benign (100%) in NM_145690.3
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), YWHAZ. . Gene score misZ 3.0961 (greater than the threshold 3.09). Trascript score misZ 4.4099 (greater than threshold 3.09). GenCC has associacion of gene with complex neurodevelopmental disorder.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.876
PP5
Variant 8-100920742-G-C is Pathogenic according to our data. Variant chr8-100920742-G-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 448894.We mark this variant Likely_pathogenic, oryginal submissions are: {not_provided=2, Pathogenic=1, Likely_pathogenic=2, Uncertain_significance=1}. Variant chr8-100920742-G-C is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
YWHAZ | NM_145690.3 | c.689C>G | p.Ser230Trp | missense_variant | 6/6 | ENST00000395958.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
YWHAZ | ENST00000395958.6 | c.689C>G | p.Ser230Trp | missense_variant | 6/6 | 1 | NM_145690.3 | P1 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD3 genomes
Cov.:
30
GnomAD4 exome Cov.: 33
GnomAD4 exome
Cov.:
33
GnomAD4 genome Cov.: 30
GnomAD4 genome
Cov.:
30
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:3Uncertain:2Other:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Other:2
not provided, no classification provided | phenotyping only | GenomeConnect, ClinGen | - | Variant interpreted as Uncertain significance and reported on 10-27-2017 by Lab or GTR ID 167595. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. - |
not provided, no classification provided | phenotyping only | GenomeConnect - CFC International | - | Variant interpreted as Uncertain significance and reported on 10-27-2017 by Lab or GTR ID 167595. GenomeConnect-CFC International assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. - |
YWHAZ-related neurodevelopmental syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Feb 20, 2023 | The YWHAZ c.689C>G (p.Ser230Trp) missense variant results in the substitution of serine at amino acid position 230 with tryptophan. This variant has been reported in a heterozygous state in a nine year old male with a clinical diagnosis of cardiofaciocutaneous syndrome. The variant occurred de novo. The individual's phenotype included short stature, global developmental delay, dysmorphic facial features, coarse, curly hair, sparse eyebrows, pulmonic stenosis, hyperkeratosis, seizures and autistic-like and self-injurious behavior (PMID: 31024343). This variant is not found in version 2.1.1 or version 3.1.2 of the Genome Aggregation Database. Ectopic expression of c.689C>G RNA in Xenopus embryos resulted in severe head and body axis malformations compared to wild type. Co-overexpression of the c.689C>G variant RNA with c-raf RNA in the same model induced elevated Erk phosphorylation compared to wild type (PMID: 31024343). This variant was identified in a de novo state. Based on the available evidence, the c.689C>G (p.Ser230Trp) variant is classified as likely pathogenic for YWHAZ-related neurodevelopmental syndrome. - |
See cases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Centre for Mendelian Genomics, University Medical Centre Ljubljana | Jul 01, 2019 | This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PS1,PS2,PS3,PM2,PP3. - |
Noonan-like disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Center For Human Genetics And Laboratory Diagnostics, Dr. Klein, Dr. Rost And Colleagues | Sep 29, 2023 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | research | HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology | Sep 26, 2017 | - - |
RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE Uncertain:1
Uncertain significance, no assertion criteria provided | literature only | OMIM | Dec 23, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
T;T;T;T;T;.;T;T;T;T;T;T;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
.;D;.;.;.;D;.;D;.;D;.;.;D
M_CAP
Benign
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
H;H;H;H;H;.;.;.;H;.;H;H;.
MutationTaster
Benign
D;D;D;D;D;D;D;D;D;D;D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D
REVEL
Uncertain
Sift
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D
Sift4G
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;.
Polyphen
D;D;D;D;D;.;.;.;D;.;D;D;.
Vest4
MutPred
Loss of disorder (P = 5e-04);Loss of disorder (P = 5e-04);Loss of disorder (P = 5e-04);Loss of disorder (P = 5e-04);Loss of disorder (P = 5e-04);.;.;.;Loss of disorder (P = 5e-04);.;Loss of disorder (P = 5e-04);Loss of disorder (P = 5e-04);.;
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AL_spliceai
Position offset: 10
Find out detailed SpliceAI scores and Pangolin per-transcript scores at